Crispr Therapeutics Ag (CRSP)

Apr 04, 2025

CRISPR Therapeutics AG (CRSP) Stock Moves -0.03%: What You Should Know - Yahoo Finance

Apr 04, 2025

Apr 04, 2025

Crispr Therapeutics gets orphan drug status for lymphoma treatment - Investing.com

Apr 04, 2025

Apr 04, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 8.7%Should You Sell? - MarketBeat

Apr 04, 2025

Apr 04, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Reaches New 1-Year LowTime to Sell? - MarketBeat

Apr 04, 2025

Apr 04, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 8.7%What's Next? - MarketBeat

Apr 04, 2025

Apr 04, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Holdings Raised by Pictet Asset Management Holding SA - MarketBeat

Apr 04, 2025

Apr 04, 2025

KLP Kapitalforvaltning AS Purchases Shares of 16,100 CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 04, 2025

Apr 04, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Stock Holdings Decreased by NEOS Investment Management LLC - MarketBeat

Apr 04, 2025

Apr 04, 2025

Blair William & Co. IL Sells 7,509 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 04, 2025

Apr 03, 2025

Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March - The Motley Fool

Apr 03, 2025

Apr 03, 2025

RBC Cuts Price Target on CRISPR Therapeutics to $38 From $48, Keeps Sector Perform, Speculative Risk - MarketScreener

Apr 03, 2025

Apr 03, 2025

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Apr 03, 2025

Apr 02, 2025

CRISPR Therapeutics (CRSP) Rebounds After Six Session Downtrend - GuruFocus

Apr 02, 2025

Apr 02, 2025

Layoff Tracker: Gilead, Sail, Carisma and More Slash Headcounts - BioSpace

Apr 02, 2025

Apr 02, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Sets New 52-Week LowTime to Sell? - MarketBeat

Apr 02, 2025

Apr 02, 2025

Top 5 CRISPR Companies To Invest In (April 2025) - Securities.io

Apr 02, 2025

Apr 02, 2025

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results - Louisiana First News

Apr 02, 2025

Apr 01, 2025

Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr. - Yahoo Finance

Apr 01, 2025

Apr 01, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by Loomis Sayles & Co. L P - MarketBeat

Apr 01, 2025

Mar 31, 2025

CRSP stock touches 52-week low at $35.52 amid market challenges By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

CRSP stock touches 52-week low at $35.52 amid market challenges - Investing.com Australia

Mar 31, 2025

Mar 31, 2025

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today - MSN

Mar 31, 2025

Mar 31, 2025

Intellia Focuses on Pipeline Development Amid Stiff Competition - Yahoo Finance

Mar 31, 2025

Mar 31, 2025

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics - Yahoo Finance

Mar 31, 2025

Mar 31, 2025

Raymond James Financial Inc. Takes $3.23 Million Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 31, 2025

Mar 30, 2025

How to Take Advantage of moves in (CRSP) - Stock Traders Daily

Mar 30, 2025

Mar 30, 2025

Avantax Advisory Services Inc. Invests $269,000 in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 30, 2025

Mar 29, 2025

HighTower Advisors LLC Has $1.25 Million Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 29, 2025

Mar 29, 2025

IQ EQ FUND MANAGEMENT IRELAND Ltd Has $1.43 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 29, 2025

Mar 28, 2025

Promising Genomics & Synthetic Biology Stocks to Consider in 2025 - Yahoo Finance

Mar 28, 2025

Mar 27, 2025

CRISPR Therapeutics (NasdaqGM:CRSP) COO Departure Announced Following 7% Share Price Decline - Yahoo Finance

Mar 27, 2025

Mar 27, 2025

Magnetar Financial LLC Acquires New Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 27, 2025

Mar 26, 2025

CRISPR Therapeutics COO to step down in April By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

CRISPR Therapeutics COO to Step Down - Marketscreener.com

Mar 26, 2025

Mar 26, 2025

CRISPR Therapeutics COO Julianne Bruno Resigns - TipRanks

Mar 26, 2025

Mar 26, 2025

CRISPR Therapeutics COO to step down in April - Investing.com

Mar 26, 2025

Mar 26, 2025

CRISPR Therapeutics Announces Transition of Chief Operating Officer - GlobeNewswire

Mar 26, 2025

Mar 26, 2025

This CRISPR Therapeutics Insider Increased Their Holding In The Last Year - Yahoo Finance

Mar 26, 2025

Mar 26, 2025

Crispr therapeutics’ general counsel sells shares worth $131,317 By Investing.com - Investing.com Australia

Mar 26, 2025

Mar 25, 2025

Is CRISPR Therapeutics AG (CRSP) a Promising Biotech Stock According to Wall Street Analysts - Insider Monkey

Mar 25, 2025

Mar 25, 2025

CRISPR Therapeutics Set To Reach Previous Heights (NASDAQ:CRSP) - Seeking Alpha

Mar 25, 2025

Mar 25, 2025

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It - MSN

Mar 25, 2025

Mar 25, 2025

Buy Rating for Crispr Therapeutics AG Driven by Promising Clinical Data and Diversified Pipeline - TipRanks

Mar 25, 2025

Mar 24, 2025

12 Most Promising Biotech Stocks According to Wall Street Analysts - Insider Monkey

Mar 24, 2025

Mar 24, 2025

Crispr therapeutics CFO Prasad Raju sells $90,582 in shares By Investing.com - Investing.com Australia

Mar 24, 2025

Mar 24, 2025

Crispr therapeutics CEO sells shares worth $413,578 By Investing.com - Investing.com South Africa

Mar 24, 2025

Mar 24, 2025

Crispr therapeutics COO Bruno Julianne sells $70,668 in stock By Investing.com - Investing.com Australia

Mar 24, 2025

Mar 24, 2025

Crispr therapeutics’ general counsel sells shares worth $131,317 - Investing.com India

Mar 24, 2025

Mar 24, 2025

Crispr therapeutics CFO Prasad Raju sells $90,582 in shares - Investing.com India

Mar 24, 2025